Deutsche Bank Remains a Buy on Novartis AG (NOVN)
Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on Novartis AG (NOVN – Research Report) today and set a price target of ...
Roche fails in bid to increase dose of MS drug Ocrevus
Roche said on Wednesday that a trial testing higher doses of its multiple sclerosis drug Ocrevus did not show an efficacy ...
ITM Appoints Dr. Celine Wilke as Chief Medical Officer
Experienced leader in radiopharmaceutical drug development, regulatory, and clinical strategies will advance ITM’s broad pipeline and clinical ...
Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600 ...
Medical Marketing & Media5d
Novartis names new chief legal and compliance officer as Klaus Moosmayer exits
Karen Hale, who joined Novartis in 2021 as chief legal officer, will take on the new chief legal and compliance officer role.
OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer
OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company dedicated to advancing healthcare outcomes and improving the ...
Swiss drugmakers Novartis and Roche ditch some diversity programmes on US concerns
By Paul Arnold, Maggie Fick ZURICH (Reuters) -Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its use of diverse panels for U.S. hiring, the ...
Reuters18d
Swiss drugmakers Novartis and Roche ditch some diversity programmes on US concerns
ZURICH, March 19 (Reuters) - Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending ... in the U.S. and at its Basel headquarters "will focus ...